title: Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
authors.affiliation: Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA. mossads@ccf.org
authors.forename: Sherif B
authors.initials: SB
authors.lastname: Mossad
authors.forename: Robin K
authors.initials: RK
authors.lastname: Avery
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Bolwell
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D015725:Fluconazole / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D009181:Mycoses / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole